Cited by 255Chronic Kidney Disease and DiabetesAdipokines, Inflammation, and Metabolic DiseasesRenal Diseases and Glomerulopathies

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

Open access

Saraheimo, M., Teppo, A.-M., Forsblom, C., Fagerudd, J., Groop, P.-H.·2003·Diabetologia

DOI 10.1007/s00125-003-1194-5

Open this paper in CoChat — free account Open PDF

Abstract

Aims/hypothesis Increased concentrations of C-reactive protein and interleukin-6, a finding suggestive of the presence of inflammation, have been observed in Type 2 diabetes. In such patients, C-reactive protein was predictive of diabetic nephropathy. Studies on low-grade inflammatory markers and nephropathy in Type 1 diabetic patients have shown conflicting results. Therefore we studied whether low-grade inflammation is associated with diabetic nephropathy in Type 1 diabetic patients.Methods We divided 194 Type 1 diabetic patients into three groups from the Finnish Diabetic Nephropathy Study based upon their albumin excretion rate. Patients with normoalbuminuria (n=67) had no antihypertensive medication or signs of cardiovascular disease, while patients with microalbuminuria (n=64) or macroalbuminuria (n=63) were all treated with an angiotensin-converting enzyme inhibitor, a drug that could attenuate low-grade inflammation. As a measure of insulin sensitivity we used estimated glucose disposal rate. C-reactive protein was measured by radioimmunoassay and interleukin-6 by high sensitivity enzyme immunoassay.Results C-reactive protein was higher in micro- and macroalbuminuric patients compared to normoalbuminuric patients (normoalbuminuria 2.0+/-1.7, microalbuminuria 2.6+/-1.7, macroalbuminuria 2.9+/-2.5 mg/l; p=0.016), while interleukin-6 increased in parallel with the severity of the renal disease (1.9+/-1.5, 2.9+/-3.3, 3.6+/-3.1 ng/l; p<0.0001). In multiple regression analysis albumin excretion rate was the only variable independently associated with C-reactive protein (p=0.03), whereas albumin excretion rate (p=0.0003), HDL-cholesterol (p=0.0135) and duration of diabetes (p=0.0176) were independently associated with interleukin-6.Conclusions/interpretation Low-grade inflammatory markers are associated with diabetic nephropathy in Type 1 diabetic patients. The predictive value needs to be assessed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-003-1194-5

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,756
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,402
High-Sensitivity C-Reactive Protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease
Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,246
Interleukin-6 induces cellular insulin resistance in hepatocytes.
Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883

Show all 26 references

Sorted by citations

Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
Inflammation and the pathogenesis of diabetic nephropathy
Wada, J., & Makino, H. (2012) · Clinical Science · doi:10.1042/cs20120198 · Cited by 793
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Self-citation
Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 706
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 530
“Diabetic nephropathy is associated with a state of lowgrade inflammation in the microvasculature of the kidney’s glomeruli [99, 100].”
Background
Inflammation in Diabetic Nephropathy
Lim, A. K. H., & Tesch, G. H. (2012) · Mediators of Inflammation · doi:10.1155/2012/146154 · Cited by 439
Metabolic Syndrome in Type 1 Diabetes
Thorn, L. M., Forsblom, C. M., Fagerudd, J. A., Thomas, M. C., Pettersson-Fernholm, K., Saraheimo, M., Wadén, J., Rönnback, M., Rosengård‐Bärlund, M., af Björkesten, C.-G., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2019 · Cited by 426
Self-citation
Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation
Lassenius, M. I., Pietiläinen, K. H., Kaartinen, K., Pussinen, P. J., Syrjänen, J., Forsblom, C. M., Pörsti, I. H., Rissanen, A., Kaprio, J. A., Mustonen, J. T., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2197 · Cited by 428
Self-citation
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
Kodera, R., Shikata, K., Kataoka, H. U., Takatsuka, T., Miyamoto, S., Sasaki, M., Kajitani, N., Nishishita, S., Sarai, K., Hirota, D., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-2028-x · Cited by 394
What Does Minor Elevation of C-Reactive Protein Signify?
Kushner, I., Rzewnicki, D., & Samols, D. R. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.057 · Cited by 372
What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
Satchell, S. C., & Tooke, J. E. (2008) · Diabetologia · doi:10.1007/s00125-008-0961-8 · Cited by 360
Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
Vestra, M. D., Mussap, M., Gallina, P., Bruseghin, M., Cernigoi, A. M., Saller, A., Plebani, M., & Fioretto, P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110961 · Cited by 299
Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis
Papadopoulou‐Marketou, N., Chrousos, G. P., & Kanaka‐Gantenbein, C. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2841 · Cited by 243
The Early Natural History of Nephropathy in Type 1 Diabetes
Mauer, M. S., Drummond, K., & for the International Diabetic Nephropathy Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1572 · Cited by 217
The Early Natural History of Nephropathy in Type 1 Diabetes
Steinke, J. M., Sinaiko, A. R., Kramer, M. S., Suissa, S., Chavers, B. M., Mauer, M., & for the International Diabetic Nephropathy Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2164 · Cited by 190
Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients With Type 1 Diabetes and Their Role in Microvascular Complications
Devaraj, S., Cheung, A., Jialal, I., Griffen, S. C., Nguyen, D. V., Glaser, N. S., & Aoki, T. T. (2007) · Diabetes · doi:10.2337/db07-0784 · Cited by 183
Targeting inflammation in diabetic nephropathy: a tale of hope
Moreno, J. A., Gómez‐Guerrero, C., Mas, S., Sanz, A. B., Lorenzo, Ó., Ruiz‐Ortega, M., Opazo-Ríos, L., Mezzano, S. A., & Egido, J. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1538352 · Cited by 174
Epidemiology and Risk Factors for Diabetic Kidney Disease
Harjutsalo, V., & Groop, P. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.009 · Cited by 165
Self-citation
C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease
Li, L., Chen, L., Zang, J., Tang, X., Liu, Y., Zhang, J., Bai, L., Yin, Q., Lu, Y., Cheng, J., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.01.014 · Cited by 157
Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury
Huang, Y., Liu, Y., Li, L., Su, B., Yang, L., Fan, W., Yin, Q., Chen, L., Cui, T., Zhang, J., et al. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-142 · Cited by 145
Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: Involvement of NF-κB signaling pathway
Jiang, Q. L., Liu, P., Wu, X., Liu, W., Shen, X., Lan, T., Xu, S., Peng, J., Xie, X. S., & Huang, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.07.023 · Cited by 144
Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts
Rizvi, A. A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181a4158c · Cited by 138
Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia
Pussinen, P. J., Kopra, E., Pietiäinen, M., Lehto, M. J., Zarić, S., Paju, S., & Salminen, A. (2022) · Periodontology 2000 · doi:10.1111/prd.12433 · Cited by 142
Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy
Saraheimo, M., Forsblom, C. M., Fagerudd, J. A., Teppo, A., Pettersson-Fernholm, K., Frystyk, J., Flyvbjerg, A., Groop, P., & on behalf of the FinnDiane Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1410 · Cited by 131
Self-citation
Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy
Targher, G., Bertolini, L., Zoppini, G., Zenari, L., & Falezza, G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01562.x · Cited by 128
Sitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals
Marques, C., Mega, C., Gonçalves, A., Rodrigues-Santos, P., Teixeira-Lemos, E., Teixeira, F., Fontes-Ribeiro, C., Reis, F., & Fernandes, R. (2014) · Mediators of Inflammation · doi:10.1155/2014/538737 · Cited by 126
“Accumulating evidences point to a critical role of inflammation and proinflammatory cytokines in the development and progression of DN [10, 11].”
Background
Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment
Kim, H. S., Ullevig, S. L., Zamora, D. A., Lee, C. F., & Asmis, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212596109 · Cited by 119
Mannose-Binding Lectin as a Predictor of Microalbuminuria in Type 1 Diabetes
Hovind, P. H., Hansen, T. K., Tarnow, L., Thiel, S., Steffensen, R., Flyvbjerg, A., & Parving, H. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1523 · Cited by 119
Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease
Suliman, M. E., Yılmaz, M. İ., Carrero, J. J., Qureshi, A. R., Sağlam, M., İpçioğlu, O. M., Yenicesu, M., Tong, M., Heimbürger, O., Barany, P. F., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03960907 · Cited by 117
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Lu, T.-C., Wang, Z., Feng, X., Chuang, P. Y., Fang, W. Y., Shen, Y., Levy, D. E., Xiong, H., Chen, N., & He, C. (2009) · Kidney International · doi:10.1038/ki.2009.98 · Cited by 114
Serum Lipopolysaccharide Activity Is Associated With the Progression of Kidney Disease in Finnish Patients With Type 1 Diabetes
Nymark, M., Pussinen, P. J., Tuomainen, A. M., Forsblom, C. M., Groop, P., Lehto, M. J., & on behalf of the FinnDiane Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0467 · Cited by 109
Self-citation
Upregulation of Angiotensin II Type 1 Receptor, Inflammatory Mediators, and Enzymes of Arachidonate Metabolism in Obese Zucker Rat Kidney
Xu, Z., Lanting, L. L., Vaziri, N. D., Li, Z., Sepassi, L., Rodríguez‐Iturbe, B., & Natarajan, R. D. (2005) · Circulation · doi:10.1161/01.cir.0000161831.07637.63 · Cited by 110
Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
Lopes-Virella, M. F., Carter, R. E., Gilbert, G. E., Klein, R. L., Jaffa, M. A., Jenkins, A. J., Lyons, T. J., Garvey, W. T., Virella, G., & and the DCCT/EDIC Cohort Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0659 · Cited by 100
Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects
Hadjadj, S., Aubert, R., Fumeron, F., Péan, F., Tichet, J., Roussel, R., Marre, M., & groups, S. A. D. S. (2005) · Diabetologia · doi:10.1007/s00125-005-1747-x · Cited by 102
The relation of C - reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study
Fox, E. R., Benjamin, E. J., Sarpong, D. F., Nagarajarao, H. S., Taylor, J. K., Steffes, M. W., Salahudeen, A. K., Flessner, M. F., Akylbekova, E. L., Fox, C. S., et al. (2010) · BMC Nephrology · doi:10.1186/1471-2369-11-1 · Cited by 98
Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes
on behalf of the FinnDiane Study Group, Hansen, T. K., Forsblom, C. M., Saraheimo, M., Thorn, L. M., Wadén, J., Høyem, P., Østergaard, J. A., Flyvbjerg, A., & Groop, P. (2010) · Diabetologia · doi:10.1007/s00125-010-1742-8 · Cited by 101
Self-citation
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice
Xiao, X., Ma, B., Dong, B., Zhao, P., Tai, N., Chen, L., Wong, F. S., & Li, W. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.12.003 · Cited by 99
Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
Lin, J., Glynn, R. J., Rifai, N., Manson, J. E., Ridker, P. M., Nathan, D. M., & Schaumberg, D. A. (2008) · Diabetes Care · doi:10.2337/dc08-0277 · Cited by 98
Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)
van den Berg, J. M. W., Morton, A. M., Kok, S. W., Pijl, H., Conway, S. P., & Heijerman, H. G. M. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.05.008 · Cited by 97
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy
Saraheimo, M., Forsblom, C. M., Hansen, T. K., Teppo, A.-M., Fagerudd, J. A., Pettersson-Fernholm, K., Thiel, S., Tarnow, L., Ebeling, P. R., Flyvbjerg, A., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1594-1 · Cited by 97
Self-citation
Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy
Wu, C., Chen, J.-S., Lu, K., Chen, C., Lin, S., Chu, P., Sytwu, H., & Lin, Y. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.036 · Cited by 92
Macrophage Scavenger Receptor-A–Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation
Usui, H. K., Shikata, K., Sasaki, M., Okada, S., Matsuda, M., Shikata, Y., Ogawa, D., Kido, Y., Nagase, R., Yozai, K., et al. (2007) · Diabetes · doi:10.2337/db06-0359 · Cited by 91
Adiponectin Is Inversely Associated with Renal Function in Type 1 Diabetic Patients
Schalkwijk, C. G., Chaturvedi, N., Schram, M. T., Fuller, J., & Stehouwer, C. D. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1117 · Cited by 94
Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
Mäkinen, V., Forsblom, C. M., Thorn, L. M., Wadén, J., Gordin, D., Heikkilä, O., Hietala, K., Kyllönen, L., Kytö, J., Rosengård‐Bärlund, M., et al. (2008) · Diabetes · doi:10.2337/db08-0332 · Cited by 92
Self-citation
IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice
Wu, R., Liu, X., Yin, J., Wu, H., Cai, X., Wang, N., Qian, Y., & Wang, F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.002 · Cited by 90
The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders
Lehto, M. J., & Groop, P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00553 · Cited by 86
Self-citation
Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes
Sigfrids, F. J., Dahlström, E. H., Forsblom, C. M., Sandholm, N., Harjutsalo, V., Taskinen, M., & Groop, P. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13298 · Cited by 87
Self-citation
Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study
Araki, S., Haneda, M., Koya, D., Sugimoto, T., Isshiki, K., Chin‒Kanasaki, M., Uzu, T., & Kashiwagi, A. (2007) · Diabetologia · doi:10.1007/s00125-006-0586-8 · Cited by 81
Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury
Liu, W., Zhang, X., Liu, P., Shen, X., Lan, T., Li, W., Jiang, Q. L., Xie, X., & Huang, H. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.033 · Cited by 82
Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study)
Mäkinen, V., Tynkkynen, T., Soininen, P., Forsblom, C. M., Peltola, T., Kangas, A. J., Groop, P., & Ala‐Korpela, M. (2011) · Metabolomics · doi:10.1007/s11306-011-0343-y · Cited by 82
Self-citation
Frequent and intensive physical activity reduces risk of cardiovascular events in type 1 diabetes
on behalf of the FinnDiane Study Group, Tikkanen-Dolenc, H., Wadén, J., Forsblom, C. M., Harjutsalo, V., Thorn, L. M., Saraheimo, M., Elonen, N., Rosengård‐Bärlund, M., Gordin, D., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4189-8 · Cited by 83
Self-citation
Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects
Lopes-Virella, M. F., Baker, N. L., Hunt, K. J., Cleary, P. A., Klein, R. L., & Virella, G. (2013) · Diabetes Care · doi:10.2337/dc12-2521 · Cited by 80
Targeting inflammation in diabetic kidney disease: early clinical trials
Pérez-Gómez, M. V., Sánchez-Niño, M. D., Sanz, A. B., Zheng-Lin, B., Martín-Cleary, C., Ruiz‐Ortega, M., Ortíz, A., & Fernández‐Fernández, B. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1196184 · Cited by 82
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes
on behalf of the FinnDiane Study Group, Thomas, M. C., Söderlund, J., Lehto, M. J., Mäkinen, V., Moran, J. L., Cooper, M. E., Forsblom, C. M., & Groop, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2186-5 · Cited by 80
Self-citation
DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats
Alam, M. A., Chowdhury, M. R. H., Jain, P., Sagor, M. A. T., & Reza, H. M. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0095-3 · Cited by 77
Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells
Xie, X., Peng, J., Huang, K., Huang, J., Shen, X., Liu, P., & Huang, H. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.008 · Cited by 76
C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes
Liu, F., Chen, H., Huang, X., Chung, A. C. K., Zhou, L., Fu, P., Szalai, A. J., & Lan, H. Y. (2011) · Diabetologia · doi:10.1007/s00125-011-2237-y · Cited by 74
Activation of Peroxisome Proliferator–Activated Receptor δ Inhibits Streptozotocin-Induced Diabetic Nephropathy Through Anti-Inflammatory Mechanisms in Mice
Matsushita, Y., Ogawa, D., Wada, J., Yamamoto, N., Shikata, K., Sato, C., Tachibana, H., Toyota, N., & Makino, H. (2011) · Diabetes · doi:10.2337/db10-1361 · Cited by 73
All-trans retinoic acid ameliorates inflammatory response mediated by TLR4/NF-κB during initiation of diabetic nephropathy
Sierra-Mondragón, E., Molina‐Jijón, E., Namorado-Tónix, C., Rodríguez‐Muñoz, R., Pedraza‐Chaverrí, J., & Reyes, J. L. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.06.002 · Cited by 72
Pattern recognition receptor‐mediated inflammation in diabetic vascular complications
Wang, X., Antony, V., Wang, Y., Wu, G., & Liang, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21711 · Cited by 73
HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes
on behalf of the FinnDiane Study Group, Hietala, K., Wadén, J., Forsblom, C. M., Harjutsalo, V., Kytö, J., Summanen, P. A., & Groop, P. (2013) · Diabetologia · doi:10.1007/s00125-012-2816-6 · Cited by 70
Self-citation
Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients
Hojs, R., Ekart, R., Bevc, S., & Hojs, N. V. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447434 · Cited by 70
Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes
Forsblom, C. M., Thomas, M. C., Moran, J. L., Saraheimo, M., Thorn, L. M., Wadén, J., Gordin, D., Frystyk, J., Flyvbjerg, A., Groop, P., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02406.x · Cited by 69
Self-citation
Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum
Mäkinen, V., Soininen, P., Forsblom, C., Parkkonen, M., Ingman, P., Kaski, K., Groop, P., & Ala-Korpela, M. (2007) · Magnetic Resonance Materials in Physics, Biology and Medicine · doi:10.1007/s10334-006-0054-y · Cited by 70
Self-citation
Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats
Liu, Y., Hao, Y., Chen, Y., Yin, S., Zhang, M., Kong, L., & Wang, T. (2018) · Phytotherapy Research · doi:10.1002/ptr.6088 · Cited by 66
Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB
Berglund, L. M., Lyssenko, V., Ladenvall, C., Kotova, O., Edsfeldt, A., Pilgaard, K. A., Alkayyali, S., Brøns, C., Forsblom, C. M., Jonsson, A. E., et al. (2015) · Diabetes · doi:10.2337/db15-0122 · Cited by 68
Self-citation
Diabetes-Induced Activation of Canonical and Noncanonical Nuclear Factor-κB Pathways in Renal Cortex
Starkey, J. M., Haidacher, S. J., LeJeune, W. S., Zhang, X., Tieu, B. C., Choudhary, S., Brasier, A. R., Denner, L. A., & Tilton, R. G. (2006) · Diabetes · doi:10.2337/db05-1554 · Cited by 65
Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease
Winter, L., Wong, L., Jerums, G., Seah, J., Clarke, M. V., Tan, S. M., Coughlan, M. T., MacIsaac, R. J., & Ekinci, E. I. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00225 · Cited by 65
Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study
on behalf of the FinnDiane Study Group, Wadén, J., Tikkanen-Dolenc, H., Forsblom, C. M., Harjutsalo, V., Thorn, L. M., Saraheimo, M., Tolonen, N., Rosengård‐Bärlund, M., Gordin, D., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3499-6 · Cited by 67
Self-citation
Intestinal alkaline phosphatase at the crossroad of intestinal health and disease – a putative role in type 1 diabetes
Lassenius, M. I., Fogarty, C. L., Blaut, M., Haimila, K., Riittinen, L., Paju, A., Kirveskari, J., Järvelä, J., Ahola, A. J., Gordin, D., et al. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12607 · Cited by 63
Self-citation
Mangiferin Attenuates Renal Fibrosis Through Down-Regulation of Osteopontin in Diabetic Rats: EFFECTS OF MANGIFERIN ON RENAL FIBROSIS IN DIABETES
Zhu, X., Cheng, Y.-Q., Du, L., Li, Y., Zhang, F., Guo, H., Liu, Y.-W., & Yin, X.-X. (2015) · Phytotherapy Research · doi:10.1002/ptr.5254 · Cited by 66
Microvascular disease in children and adolescents with type 1 diabetes and obesity
Marcovecchio, M. L., & Chiarelli, F. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1624-9 · Cited by 60
Complement deposition on renal histopathology of patients with diabetic nephropathy
Sun, Z., Li, X.-Q., Chang, D., Wang, S.-X., Liu, G., Chen, M., & Zhao, M. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.08.011 · Cited by 58
Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats
Chung, S., Park, C. W., Shin, S. J., Lim, J. H., Chung, H. W., Youn, D., Kim, H., Kim, B. S., Lee, J. H., Kim, G., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp472 · Cited by 58
High levels of circulating interleukin-10 in diabetic nephropathy patients.
Myśliwska, J. M., Zorena, K., Semetkowska-Jurkiewicz, E., Rachoń, D., Suchanek, H., & Myśliwski, A. (2005) · PubMed · Cited by 58
Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia
Aso, Y., Yoshida, N., Okumura, K.-I., Wakabayashi, S., Matsutomo, R., Takebayashi, K., & Inukai, T. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.05.006 · Cited by 56
Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade
Lanza, G. A., Pitocco, D., Navarese, E. P., Sestito, A., Sgueglia, G. A., Manto, A., Infusino, F., Musella, T., Ghirlanda, G., & Crea, F. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm018 · Cited by 55
Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study
Simonsen, J. R., Harjutsalo, V., Järvinen, A., Kirveskari, J., Forsblom, C. M., Groop, P., & Lehto, M. J. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000067 · Cited by 55
Self-citation
Activation of Liver X Receptor Inhibits Osteopontin and Ameliorates Diabetic Nephropathy
Tachibana, H., Ogawa, D., Matsushita, Y., Bruemmer, D., Wada, J., Teshigawara, S., Eguchi, J., Horiguchi, C. S., Uchida, H. A., Shikata, K., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010022 · Cited by 54
C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia
Haidet, J., Cifarelli, V., Trucco, M., & Luppi, P. (2011) · Inflammation Research · doi:10.1007/s00011-011-0384-8 · Cited by 52
Epigenetics and Inflammation in Diabetic Nephropathy
Shao, B., Zhang, S., Li, H.-D., Meng, X., & Chen, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.649587 · Cited by 54
Does microalbuminuria predict illness severity in critically ill patients on the intensive care unit? A systematic review*
Gopal, S., Carr, B., & Nelson, P. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217922.75068.ea · Cited by 52
Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes
Gordin, D., Forsblom, C. M., Rönnback, M., Parkkonen, M., Wadén, J., Hietala, K., & Groop, P. (2008) · Annals of Medicine · doi:10.1080/07853890802126547 · Cited by 52
Self-citation
Exosomes from high glucose-treated macrophages activate macrophages andinduce inflammatory responses via NF-κB signaling pathway in vitro and in vivo
Zhu, M. J., Sun, X., Qi, X., Xia, L., & Wu, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106551 · Cited by 51
Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients.
Shelbaya, S., Amer, H., Seddik, S., Aa, A., Im, S., Mohamed, T. Y. H., & El Mosely, M. (2012) · PubMed · Cited by 50
Does fenugreek ( Trigonella foenum-graecum ) seed improve inflammation, and oxidative stress in patients with type 2 diabetes mellitus? A parallel group randomized clinical trial
Tavakoly, R., Maracy, M. R., Karimifar, M., & Entezari, M. H. (2018) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2018.01.005 · Cited by 52
The effects of hesperidin and quercetin on serum tumor necrosis factor-alpha and interleukin-6 levels in streptozotocin-induced diabetes model
İskender, H., Dokumacıoğlu, E., Şen, T. M., İnce, İ., Dokumacıoğlu, A., Kanbay, Y., Erbaş, E., & Saral, S. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_41_17 · Cited by 50
The Serum IL-6 Profile and Treg/Th17 Peripheral Cell Populations in Patients with Type 1 Diabetes
Ryba-Stanisławowska, M. E., Skrzypkowska, M. W., Myśliwska, J. M., & Myśliwiec, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/205284 · Cited by 49
Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes
Forsblom, C. M., Moran, J. L., Harjutsalo, V., Loughman, T., Wadén, J., Tolonen, N., Thorn, L. M., Saraheimo, M., Gordin, D., Groop, P., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0225 · Cited by 49
Self-citation
Association Between IL-6 Concentration and Diabetes-Related Variables in DM1 Patients with and without Microvascular Complications
Wegner, M., Araszkiewicz, A., Pioruńska-Stolzmann, M., Wierusz‐Wysocka, B., & Zozulińska‐Ziółkiewicz, D. (2013) · Inflammation · doi:10.1007/s10753-013-9598-y · Cited by 48
C-peptide and long-term complications of diabetes
Luppi, P., Cifarelli, V., & Wahren, J. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00729.x · Cited by 48
An IL-6 haplotype on human chromosome 7p21 confers risk for impaired renal function in type 2 diabetic patients
Ng, D., Nurbaya, S., Ye, S., & Królewski, A. S. (2008) · Kidney International · doi:10.1038/ki.2008.202 · Cited by 47
Are C-Reactive Protein Associated Genetic Variants Associated with Serum Levels and Retinal Markers of Microvascular Pathology in Asian Populations from Singapore?
Dorajoo, R., Li, R., Ikram, M. K., Liu, J., Froguel, P., Lee, J., Sim, X., Ong, R. T., Tay, W. T., Chen, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067650 · Cited by 47
Biomarkers of Renal Disease and Progression in Patients with Diabetes
Hojs, R., Ekart, R., Bevc, S., & Hojs, N. V. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4051010 · Cited by 46
Silencing of USP22 suppresses high glucose-induced apoptosis, ROS production and inflammation in podocytes
Shi, J., Wang, Q.-J., Li, H., & Huang, Q. (2016) · Molecular BioSystems · doi:10.1039/c5mb00722d · Cited by 46
Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy
Dominguez, J. H., Wu, P., Packer, C. S., Temm, C. J., & Kelly, K. J. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00021.2007 · Cited by 46
Trigonelline inhibits caspase 3 to protect β cells apoptosis in streptozotocin-induced type 1 diabetic mice
Liu, L., Du, X., Zhang, Z., & Zhou, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.025 · Cited by 45
Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes mellitus (T1DM) in Norway
Skrivarhaug, T., Bangstad, H., Stene, L. C., Sandvik, L., Hanssen, K. F., & Joner, G. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00204.x · Cited by 44
Diabetes and Its Complications: Therapies Available, Anticipated and Aspired
Grover, A., Sharma, K., Gautam, S., Gautam, S., Gulati, M., & Singh, S. K. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666201103144231 · Cited by 47

Authors: Saraheimo, M., Teppo, A.-M., Forsblom, C., Fagerudd, J., & Groop, P.-H.
Affiliations: University of Helsinki (FI)
Helsinki University Hospital (FI)
Corresponding author: Groop, P.-H.
ORCID: Forsblom, C.
Groop, P.-H.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2003-10-01
Volume: 46
Issue: 10
Pages: 1402-1407
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-003-1194-5
OpenAlex: W1998378885
Cited by: 255
References: 26
Citations by year: 2026: 2 · 2025: 5 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 7 · 2019: 5 · 2018: 17 · 2017: 8 · 2016: 12 · 2015: 11 · 2014: 17 · 2013: 15 · 2012: 16
FWCI: 6.14
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
Wilhelm och Else Stockmanns Stiftelse
Finska Läkaresällskapet
Folkhälsanin Tutkimussäätiö
Kuopion Yliopistollinen Sairaala
Samfundet Folkhälsan
Tays
Topics: Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
Keywords: diabetic nephropathy, type 1 diabetes, low-grade inflammation, C-reactive protein, interleukin-6, urinary albumin excretion rate, microalbuminuria, macroalbuminuria, HDL cholesterol, insulin sensitivity, glucose disposal rate, ACE inhibitors, diabetes duration
MeSH terms: Adult, Albuminuria, C-Reactive Protein, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Female, Humans, Inflammation, Cholesterol, HDL, Male, Severity of Illness Index, Time Factors, Biomarkers, Interleukin-6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks